$1.44
▲ +$0.02
(+1.41%)
Vol 37K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$64.4M
ROE
-19.1%
Margin
-2454.9%
D/E
0.00
Beta
0.53
52W
$1–$2
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
COEP
Coeptis Therapeutics Holdings Inc
$76.1M
XGN
Exagen Inc
$137.8M
EXOZ
eXoZymes Inc
$91.4M
PMVP
PMV Pharmaceuticals Inc
$66.5M
BYSI
Beyondspring Inc
$67.0M
DWTX
Dogwood Therapeutics Inc
$123.7M
XBIT
XBiotech Inc
$72.9M
CYPH
Cypherpunk Technologies Inc
$65.7M
IBIO
iBio Inc
$43.4M
ACET
Adicet Bio Inc
$80.7M
Earnings
Beat rate: 100.0%
Next Report
May 11, 2026
EPS Estimate: $-0.07
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.07 | — | — |
| Dec 2025 | $-0.10 | $-0.05 | +$0.05 |
| Sep 2025 | $-0.10 | $-0.06 | +$0.04 |
| Jun 2025 | $-0.10 | $-0.07 | +$0.03 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -17.4% | -15.1% | -17.4% | -17.4% | -17.4% | -19.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -2437.7% | -72.0% | -2437.7% | -2437.7% | -2437.7% | -2454.8% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 13.26 | 17.66 | 13.26 | 13.26 | 13.26 | 9.86 |
Key Ratios
ROA (TTM)
-17.9%
P/S (TTM)
249.62
P/B
2.0
EPS (TTM)
$-0.19
CF/Share
$-0.19
52W High
$2.20
52W Low
$1.13
$1.13
52-Week Range
$2.20
How does MNOV compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MNOV valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
249.6
▲
1843%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.0
▼
20%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MNOV profitability vs Biotechnology peers
ROE
-19.1%
▲
72%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-2454.9%
▼
756%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
100.0%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-17.9%
▲
62%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
MNOV financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
9.9
▲
122%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.5
▼
45%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
MNOV fundamentals radar
MNOV
Peer median
Industry
MNOV profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MNOV vs peers: key metrics
Latest News
No related news yet